|
|
|
Sept • Oct Issue
Biomedicine | By Katherine Bourzac | 4 Comments
Venter Institute researchers have made the first viable cell with a synthetic genome.
Once again, federal funding restrictions cast uncertainty over the field.
|
|
More Briefings |
|
|
|
|
|
|
|
|
|
Community |
Most Commented |
Shared | ||
Active Discussions
Readers Favorites
|
|
|||
Log InVideos
RSS Feeds
Subscribe to Technology Review's daily e-mail update. Enter your e-mail address
|
|
| © 2010 Technology Review. All Rights Reserved. |